SODIUM CHLORIDE 0.9% W/V (IV) INFUSION 500ML

Indications

Approved Uses

Extracellular fluid volume replacement (e.g., dehydration/hypovolemia) and replacement of sodium/chloride deficits; also used as a compatible vehicle/diluent for IV medications and for line flushing/priming in clinical procedures per institutional protocols.

Off-Label Uses

For this IV infusion bag product, common off-label/institutional uses include IV line flushing/keep-vein-open (KVO) and priming/rinsing of extracorporeal circuits (e.g., dialysis) per protocol; wound/eye/nasal uses and nebulization are generally performed with products specifically labeled/packaged for irrigation/inhalation/ophthalmic use rather than an IV infusion bag.

Dosage & Administration

Dosing by Condition

Dose is individualized; for adult hypovolemia/resuscitation, give IV boluses (commonly 500 mL aliquots, reassessing frequently; or ~20-30 mL/kg in shock per resuscitation protocols) and titrate to hemodynamics/urine output; for maintenance, use patient-specific daily fluid requirements and electrolyte monitoring; as a drug diluent/vehicle, use the volume specified by the medication/institutional protocol.

Initial Dose

Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient

Maintenance Dose

For adults, daily requirements are often met by 1 liter of 0.9% sodium chloride. The rate depends on the patient's clinical condition.

Maximum Dose

No fixed maximum dose; volume/rate must be individualized to indication and patient status with ongoing monitoring (I&O, weight, electrolytes, acid-base).

Children's Dosage

Neonates and children: 10-20 ml/kg IV bolus for fluid resuscitation; maintenance calculated by Holliday-Segar method; adjust based on weight, clinical status, and electrolytes

Dose Adjustment Notes

Use caution and consider reduced volume/rate in patients at risk of sodium/water retention (e.g., heart failure, renal impairment, cirrhosis/edematous states); adjust based on clinical response, fluid balance, and serum electrolytes/acid-base status; avoid rapid correction of chronic hyponatremia (generally limit serum Na rise to ≤8-10 mmol/L in 24 h).

How to Take

For intravenous infusion (parenteral use) only via a sterile IV administration set; administer under healthcare professional supervision with the infusion rate and volume individualized to the clinical indication and patient status; inspect the solution and bag for clarity/particulates/leaks before use; single-use bag-discard any unused portion and do not reconnect partially used bags.

How to Prepare

Ready-to-use IV infusion; no reconstitution required. If used as a diluent/vehicle, add only compatible medications using aseptic technique, mix gently/adequately, and inspect for particulate matter/discoloration; use single-use bag and follow the added drug’s preparation/stability instructions.

Side Effects

Common Side Effects

Fluid overload/hypervolemia (e.g., peripheral or pulmonary edema), hypernatremia, hyperchloremia with possible hyperchloremic metabolic acidosis (especially with large volumes), and infusion-site reactions including pain, phlebitis, and thrombosis.

Side Effect Frequency

Frequency varies by volume/rate and patient factors; commonly reported: infusion-site reactions (pain, erythema, swelling), phlebitis/thrombophlebitis, and fluid overload/peripheral edema (especially with large volumes or cardiac/renal impairment). With large-volume or prolonged use: hypernatremia, hyperchloremia and hyperchloremic metabolic acidosis may occur; serious events include pulmonary edema/heart failure exacerbation (frequency not reliably quantifiable).

Safety & Warnings

Contraindications

None known

Warnings & Precautions

Monitor fluid balance, electrolytes (Na/Cl/K), and acid-base status during therapy; use caution in heart failure, renal impairment, cirrhosis/ascites, hypertension, edema, and patients at risk of hypernatremia; avoid rapid/large-volume infusion unless indicated; ensure solution clarity/aseptic technique and follow IV administration safety (e.g., avoid series connections that increase air embolism risk).

Age Restriction

No specific age restriction; can be used in all ages (including neonates/infants) with individualized dosing, rate control, and close monitoring.

Drug Interactions

Drug Interactions

Clinically relevant: corticosteroids/corticotropin (↑ sodium and fluid retention) and lithium (changes in sodium/volume status can alter lithium levels-risk of toxicity with sodium depletion). Compatibility: amphotericin B and diazepam may be physically incompatible with 0.9% NaCl depending on formulation-follow Y-site/compatibility references.

Interaction Severity

MODERATE: Corticosteroids/corticotropin (additive sodium and water retention → edema/HTN/heart failure risk). MODERATE: Lithium (changes in sodium/fluid balance can alter renal lithium handling and serum levels). Compatibility interactions (e.g., amphotericin B) are product/line-specific and should be managed via IV compatibility references rather than labeled as a universal 'major' drug interaction.

Food Interaction

No clinically relevant food interactions (not applicable for an IV infusion).

Special Populations

Children

Neonates and children: 10-20 ml/kg IV bolus for fluid resuscitation; maintenance calculated by Holliday-Segar method; adjust based on weight, clinical status, and electrolytes

Kidney Impairment

No formal dose adjustment; use great caution in renal impairment/oliguria-reduce volume/rate and monitor closely for sodium retention and fluid overload; consider renal replacement therapy if overload is refractory.

Storage & Patient Advice

Preparation Instructions

Ready-to-use IV infusion; no reconstitution required. If used as a diluent/vehicle, add only compatible medications using aseptic technique, mix gently/adequately, and inspect for particulate matter/discoloration; use single-use bag and follow the added drug’s preparation/stability instructions.

Missed Dose

Not applicable-administered in a monitored clinical setting; if an infusion is interrupted or a scheduled volume is missed, the clinician should reassess the patient’s fluid/electrolyte status and restart/adjust as indicated.

Stopping the Medicine

No taper required; stop/adjust infusion based on clinical status and monitoring, typically by healthcare professionals.

Overdose

Overdose/excess infusion may cause hypervolemia with pulmonary/peripheral edema and hypertension, hypernatremia, hyperchloremia and hyperchloremic metabolic acidosis; severe hypernatremia can cause CNS symptoms (confusion, seizures, coma). Management: stop/reduce infusion, supportive care, correct electrolytes/acid-base, consider loop diuretics; dialysis may be needed if severe overload with renal failure.

Patient Counseling

Administered intravenously by healthcare professionals in a clinical/hospital setting (do not self-administer). Used for fluid/electrolyte replacement and/or as a vehicle/diluent for compatible IV medicines. Report immediately: shortness of breath, chest tightness, new/worsening swelling (hands/ankles/feet), rapid weight gain, or reduced urine output (possible fluid overload/pulmonary edema); also report infusion-site pain, redness, swelling, or burning (possible extravasation/phlebitis). Bag is single-use; do not use if leaking, cloudy, or if seal is broken.

Monitoring Requirements

Monitor vital signs and clinical perfusion, strict input/output and daily weight when appropriate, serum electrolytes (Na, Cl, K) and renal function, and acid-base status with large volumes; watch for fluid overload (edema, crackles, rising JVP) and infusion-site complications (phlebitis/infiltration).

Pharmacology

Mechanism of Action

Provides isotonic sodium and chloride to expand extracellular fluid volume and replace Na+/Cl− deficits; being near iso-osmotic with plasma, it distributes within the extracellular compartment and supports osmotic pressure and fluid balance.

Onset of Action

Immediate upon IV administration.

Duration of Effect

Onset is immediate during infusion; intravascular volume expansion is transient with redistribution into the extracellular space within ~30-60 minutes after a bolus (only a minority remains intravascular), and the overall effect depends on the infused volume/rate and ongoing losses.

Half-Life

No clinically meaningful elimination half-life is defined for 0.9% sodium chloride; it rapidly distributes within the extracellular fluid, and sodium/chloride levels are governed by ongoing renal regulation rather than a fixed half-life.

Bioavailability

100% (intravenous administration).

Metabolism

Not metabolized.

Excretion

Primarily renal: sodium and chloride are filtered and variably reabsorbed by the kidneys; excess is excreted in urine (with minor losses via sweat/GI).

Protein Binding

Not protein bound (exists as free ions in plasma).

Product Information

Available Dosage Forms

Intravenous infusion (bag) for parenteral use.

Composition per Dose

Each 500 ml bag: 4.5 g sodium chloride (9 mg/ml); provides Na+ 154 mEq/L and Cl- 154 mEq/L; osmolarity approximately 308 mOsm/L

Generic Availability

Yes

OTC Alternatives

No OTC alternative for IV use; oral rehydration salts available OTC for mild dehydration

Primary Use

Intravenous fluid and electrolyte replacement; used to restore extracellular fluid volume and sodium-chloride balance in dehydration, hypovolemia, and as a diluent for IV medications

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.